eTheRNA Immunotherapies NV is developing immunotherapy and vaccine products for the treatment of cancer and infectious disease from its multiple RNA, formulation and manufacturing technology platforms. The private company is headquartered in Belgium and was established in 2013. eTheRNA also has offices in New York and Hong Kong. To date, the Company has raised €63 million in venture capital.

External Links


Health Band Brochure <br />

Team Members


Volker Germaschewski

Senior Vice President - Research & Development

Michael Mulqueen

Michael Mulqueen

Vice President of Business Development

Bernard Sagaert

Bernard Sagaert

COO & Senior Vice President of Manufacturing